Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

Ravegnini, G., M. Del Re (Marzia), Grolla, A.A., R.H.N. van Schaik (Ron) and Angelini, S.

2020-10-07

Additional Metadata
Keywords	liquid biopsy, precision oncology, ctDNA (circulating tumor DNA), Circulating molecular marker, personalized medicine
Persistent URL	doi.org/10.3389/fphar.2020.598261, hdl.handle.net/1765/131409
Journal	Frontiers in Pharmacology
Organisation	Department of Clinical Chemistry
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ravegnini, G., Del Re, M, Grolla, A.A., van Schaik, R.H.N, & Angelini, S. (2020). Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.598261

Publication